Click here for PDF Edition

2017-12-15 digital edition
TODAY in the Jewish World:

Click on logo for link:

Click on logo for link:

The Jewish Press of Tampa and the Jewish Press of Pinellas County are Independently- owned biweekly Jewish community newspapers published in cooperation with and supported by the Tampa JCC & Federation and the Jewish Federation of Pinellas & Pasco Counties, respectively. Copyright © 2009-2019 The Jewish Press Group of Tampa Bay, Inc., All Rights Reserved. 


December 15, 2017  RSS feed
World News

Text: T T T

Israeli drug maker to lay off 14,000 workers

JERUSALEM (JTA) – Israelbased Teva Pharmaceutical Industries, one of the largest manufacturers of generic drugs in the world, will lay off 14,000 workers as part of a global restructuring, or 25 percent of its workforce.

Teva made the announcement on Thursday, Dec. 14. The cuts will take place over the next two years, with most in 2018, The Associated Press reported.

After the cuts are completed, only 8 percent of Teva’s employees will be Israeli, the Israeli business daily Globes reported. Teva, based in Petach Tikvah, is the country’s largest private sector employer with nearly 7,000 employees in Israel. The cuts will reduce the number to about 4,000.

Teva stock has fallen 60 percent in the past year. The company also took a hit from the expiration of its patents on Copaxone, its drug for multiple sclerosis, and is struggling under a $35 billion debt from its acquisition of Allergan’s Anda generic drug division.

The company said it will be closing or selling plants in Israel as well as the United States and Europe.

Israeli Prime Minister Benjamin Netanyahu spoke with Teva CEO Kare Schultz, who was hired six weeks ago to turn the company’s fortunes, following the announcement.

According to a statement from the Prime Minister’s Office, Netanyahu asked Schultz to minimize the damage to Israeli workers, especially in the periphery of the country where two Teva factories reportedly will close.

Schultz said he would make a “supreme effort” to reduce the damage to the company’s employees, the statement said.

Netanyahu also asked Schultz to do everything possible to preserve Teva’s identity as an Israeli company, according to the statement.

Post new comment

The content of this field is kept private and will not be shown publicly.
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Click ads below for larger version